Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 2
2008 1
2009 3
2010 2
2011 3
2012 4
2013 1
2014 1
2015 1
2017 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
Claudins: Beyond Tight Junctions in Human IBD and Murine Models.
Čužić S, Antolić M, Ognjenović A, Stupin-Polančec D, Petrinić Grba A, Hrvačić B, Dominis Kramarić M, Musladin S, Požgaj L, Zlatar I, Polančec D, Aralica G, Banić M, Urek M, Mijandrušić Sinčić B, Čubranić A, Glojnarić I, Bosnar M, Eraković Haber V. Čužić S, et al. Among authors: hrvacic b. Front Pharmacol. 2021 Nov 17;12:682614. doi: 10.3389/fphar.2021.682614. eCollection 2021. Front Pharmacol. 2021. PMID: 34867313 Free PMC article.
Porphyrins as new endogenous anti-inflammatory agents.
Jelić D, Tatić I, Trzun M, Hrvačić B, Brajša K, Verbanac D, Tomašković M, Čulić O, Antolović R, Glojnarić I, Weygand-Đurašević I, Vladimir-Knežević S, Mildner B. Jelić D, et al. Among authors: hrvacic b. Eur J Pharmacol. 2012 Sep 15;691(1-3):251-60. doi: 10.1016/j.ejphar.2012.05.049. Epub 2012 Jun 9. Eur J Pharmacol. 2012. PMID: 22687816
Macrolactonolides: a novel class of anti-inflammatory compounds.
Tomašković L, Komac M, Makaruha Stegić O, Munić V, Ralić J, Stanić B, Banjanac M, Marković S, Hrvačić B, Čipčić Paljetak H, Padovan J, Glojnarić I, Eraković Haber V, Mesić M, Merćep M. Tomašković L, et al. Among authors: hrvacic b. Bioorg Med Chem. 2013 Jan 1;21(1):321-32. doi: 10.1016/j.bmc.2012.10.036. Epub 2012 Oct 30. Bioorg Med Chem. 2013. PMID: 23199485
N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Bosnar M, Kragol G, Koštrun S, Vujasinović I, Bošnjak B, Bencetić Mihaljević V, Marušić Ištuk Z, Kapić S, Hrvačić B, Brajša K, Tavčar B, Jelić D, Glojnarić I, Verbanac D, Culić O, Padovan J, Alihodžić S, Eraković Haber V, Spaventi R. Bosnar M, et al. Among authors: hrvacic b. J Med Chem. 2012 Jul 12;55(13):6111-23. doi: 10.1021/jm300356u. Epub 2012 Jun 25. J Med Chem. 2012. PMID: 22697905
Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis.
Desroy N, Housseman C, Bock X, Joncour A, Bienvenu N, Cherel L, Labeguere V, Rondet E, Peixoto C, Grassot JM, Picolet O, Annoot D, Triballeau N, Monjardet A, Wakselman E, Roncoroni V, Le Tallec S, Blanque R, Cottereaux C, Vandervoort N, Christophe T, Mollat P, Lamers M, Auberval M, Hrvacic B, Ralic J, Oste L, van der Aar E, Brys R, Heckmann B. Desroy N, et al. Among authors: hrvacic b. J Med Chem. 2017 May 11;60(9):3580-3590. doi: 10.1021/acs.jmedchem.7b00032. Epub 2017 May 1. J Med Chem. 2017. PMID: 28414242
Azithromycin inhibits macrophage interleukin-1β production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia.
Bosnar M, Čužić S, Bošnjak B, Nujić K, Ergović G, Marjanović N, Pašalić I, Hrvačić B, Polančec D, Glojnarić I, Eraković Haber V. Bosnar M, et al. Among authors: hrvacic b. Int Immunopharmacol. 2011 Apr;11(4):424-34. doi: 10.1016/j.intimp.2010.12.010. Epub 2010 Dec 30. Int Immunopharmacol. 2011. PMID: 21195124
19 results